Efficacy and Safety of Tegoprazan Versus Esomeprazole-containing Bismuth Quadruple Therapy for Eradication of Helicobacter Pylori
Condition: Helicobacter Pylori Infection Intervention: Drug: Tegoprazan Sponsor: Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials